Change of Adviser

Paris, France and Camberley, UK – 2 August 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that SP Angel Corporate Finance LLP will be the sole broker to the Company with immediate effect. http://novacyt.com/wp-content/uploads/2019/08/Novacyt-Change-of-Adviser-FR-02.08.19.pdf

Visit Page

Half-Year Trading Update Group revenues up 12% to €7.2m

Paris, France and Camberley, UK – 30 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited half year revenue update for the six months ended 30 June 2019. http://novacyt.com/wp-content/uploads/2019/07/Half-year-Trading-Update-FINAL.pdf

Visit Page

Sale of Clinical Lab

Novacyt continues to focus on driving value from its core businesses Paris, France and Camberley, UK – 18 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces it has completed the sale of its clinical laboratory business (the “Clinical Lab”) to Cambridge Pathology BV (the “Buyer”) for a

Visit Page